Fri, Apr 18, 2014, 3:15 PM EDT - U.S. Markets closed for Good Friday


% | $
Quotes you view appear here for quick access.

Biodel Inc. (BIOD) Message Board

  • buckfarmer777 buckfarmer777 Apr 15, 2013 10:17 PM Flag

    New article by Chemistfrog with BIOD being mentioned

    On Market Playground: Here is an excerpt....

    Biodel Inc. (NASDAQ:BIOD) is a development phase pharmaceutical company focusing on the large market indication of diabetes. Last Monday, BIOD common shares started the week with a dip below $2.50 per share, the lowest the stock has traded since January 23rd. However, a high-volume day Wednesday pushed shares up, closing the week at $2.91. With no news of note, I believe investor interest is beginning to return in anticipation of a couple of significant upcoming catalysts.

    On March 28th, Biodel announced that it had completed enrollment in a 130 patient phase 2 trial evaluating its ultra-rapid-acting prandial (mealtime) insulin candidate BIOD-123 for the treatment of diabetes. The trial is evaluating BIOD-123 versus standard of care Humalog in Type 1 diabetes patients as fast-acting meal-time insulin products for an 18-week period. In an earlier phase 1 trial evaluating two of Biodel’s clinical candidates in order to ascertain which would go onto the phase 2 clinical trial, BIOD-123 demonstrated that it was 64% faster than Humalog in mean times to half maximum insulin concentrations (p

    Sentiment: Buy

2.38-0.02(-0.83%)Apr 17 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Weibo Corporation
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT
SandRidge Energy, Inc.
NYSEThu, Apr 17, 2014 4:01 PM EDT